Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-cyano-3,12-dioxoolean-1,9-dien-28-oic Acid Methyl Ester
2. Cddo Methyl Ester
3. Cddo-me
4. Methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate
5. Rta-402
1. 218600-53-4
2. Cddo-me
3. Cddo Methyl Ester
4. Rta 402
5. Nsc 713200
6. Cddo-methyl Ester
7. Rta-402
8. Nsc713200
9. Rta402
10. Methyl (4as,6ar,6bs,8ar,12as,14ar,14bs)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate
11. Tp-155
12. Ceg1q6ogu1
13. Bardoxolone Methyl [usan]
14. Nsc-713200
15. Methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate
16. 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic Acid Methyl Ester
17. Methyl (4as,6ar,6bs,12as,14ar,14br)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate
18. Bardoxolone-methyl
19. (4as,6ar,6bs,8ar,12as,14ar,14bs)-methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate
20. Mfcd11983137
21. Ncgc00186460-01
22. Bardoxolone (methyl)
23. Bardoxolone Methyl Ester
24. Unii-ceg1q6ogu1
25. Cddo-me, 2
26. Dsstox_cid_28690
27. Dsstox_rid_82960
28. Dsstox_gsid_48764
29. Methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate
30. Gtpl3443
31. Bardoxolone Methyl (jan/usan)
32. Bardoxolone Methyl [jan]
33. Chembl1762621
34. Dtxsid5048764
35. Schembl12521530
36. Chebi:177406
37. 2-cyano-3,12-dioxoolean-1,9-dien-28-oic Acid Methyl Ester
38. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Methyl Ester
39. Bdbm217379
40. Bardoxolone Methyl [who-dd]
41. Bcp04660
42. Zinc3982151
43. Tox21_113229
44. S8078
45. Bardoxolone Methyl Ester [mi]
46. Akos025401880
47. Ccg-269743
48. Cs-0598
49. Db05983
50. Cddo Methyl Ester, >=98% (hplc)
51. Ac-26830
52. Csa:218600-53-4;bardoxolone Methyl
53. Hy-13324
54. Cas-218600-53-4
55. D09585
56. Nsc 713200; Rta 402; Cddo Methyl Ester
57. A847580
58. Q4860208
59. (+)-methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate
60. (4as,6ar,6bs,8ar,12as,14bs)-methyl 11-cyano-2,2,6a,6b,9,9,12a-he
61. Oleana-1,9(11)-dien-28-oic Acid, 2-cyano-3,12-dioxo-, Methyl Ester
| Molecular Weight | 505.7 g/mol |
|---|---|
| Molecular Formula | C32H43NO4 |
| XLogP3 | 6.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 505.31920885 g/mol |
| Monoisotopic Mass | 505.31920885 g/mol |
| Topological Polar Surface Area | 84.2 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1210 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in lymphoma (unspecified), multiple myeloma, and solid tumors.
Treatment of Alport syndrome
RTA 402 inhibits the activity of nuclear factor kappa-B (NF-kB) activated by tumor necrosis factor (TNF) and other inflammatory agents in a variety of cancer cells. It is a novel targeted cancer therapy with a unique mechanism of action. It exploits fundamental physiological differences between cancerous and noncancerous cells by modulating oxidative stress response pathways. As a result, the drug is toxic to cancer cells but induces protective antioxidant and anti-inflammatory responses in normal cells.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
77
PharmaCompass offers a list of Bardoxolone Methyl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bardoxolone Methyl manufacturer or Bardoxolone Methyl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bardoxolone Methyl manufacturer or Bardoxolone Methyl supplier.
PharmaCompass also assists you with knowing the Bardoxolone Methyl API Price utilized in the formulation of products. Bardoxolone Methyl API Price is not always fixed or binding as the Bardoxolone Methyl Price is obtained through a variety of data sources. The Bardoxolone Methyl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bardoxolone Methyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bardoxolone Methyl, including repackagers and relabelers. The FDA regulates Bardoxolone Methyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bardoxolone Methyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bardoxolone Methyl supplier is an individual or a company that provides Bardoxolone Methyl active pharmaceutical ingredient (API) or Bardoxolone Methyl finished formulations upon request. The Bardoxolone Methyl suppliers may include Bardoxolone Methyl API manufacturers, exporters, distributors and traders.
Bardoxolone Methyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bardoxolone Methyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bardoxolone Methyl GMP manufacturer or Bardoxolone Methyl GMP API supplier for your needs.
A Bardoxolone Methyl CoA (Certificate of Analysis) is a formal document that attests to Bardoxolone Methyl's compliance with Bardoxolone Methyl specifications and serves as a tool for batch-level quality control.
Bardoxolone Methyl CoA mostly includes findings from lab analyses of a specific batch. For each Bardoxolone Methyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bardoxolone Methyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Bardoxolone Methyl EP), Bardoxolone Methyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bardoxolone Methyl USP).
